Interim report
Page 1
OPTICEPT TECHNOLOGIES Q2 April - June Unleashing the full potential of organic material OptiCept Technologies AB (publ.) Org.Nr. 556844-3914 Skiffervägen 12, 224 78 Lund opticept.se INTERIM REPORT
Page 2
1 OPTICEPT TECHNOLOGIES SIGNIFICANT EVENTS AFTER PERIOD END FINANCIAL RESULTS & COMPANY UPDATES • OptiCept – Delivers positive results in Indonesian forestry trials • Change of Chairman of the Board – OptiCept Technologies AB • OptiCept Technologies AB (publ) – First licence fee from FPS and payment for the divestment of inventory received. Revenue amounts to SEK 21 million. • Nicklas Margård and Ulf Hagman step down from the Board of Directors at the Annual General Meeting. • The Annual General Meeting was held on 21 May 2026. • Notice of Annual General Meeting in OptiCept Technologies AB (publ) • OptiCept Technologies AB publishes Annual Report for 2025 • Communiqué from the Annual General Meeting of OptiCept Technologies AB (publ) on 21 May 2026 • OptiCept included in new order for FPS • OptiCept Technologies AB (publ) Interim Report for the First Quarter 2026 • OptiCept – New order for FPS USA • OptiCept – Additional order for FPS in the Netherlands • OptiCept resolves on a directed share issue SIGNIFICANT EVENTS DURING Q2 2026 FINANCIAL OVERVIEW KSEK (unless otherwise stated)* Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) 2026 2025 2026 2025 Net Sales** 23 302 1 192 31 139 6 470 Operating Income -15 661 -31 514 -46 575 -59 422 Result for the period -16 426 -31 959 -52 412 -60 781 Inbound Orders 171 851 15 801 174 001 17 933 Open orders 150 654 19 457 150 654 19 457 Reported EBITDA -5 361 -16 451 -20 735 -29 292 Balance sheet total 84 994 166 437 84 994 166 437 Cash & bank holdings 3 600 12 043 3 600 12 043 Equity 35 731 123 763 35 731 123 763 Equity ratio (%) 38% 74% 38% 74% Average number of shares in the period 85 895 127 62 823 850 77 216 844 62 823 850 Number of shares at the end of the period 86 088 714 64 394 683 86 088 714 64 394 683 Earnings per share before and after dilution (SEK) -0.19 -0.51 -0.68 -0.97 Cash flow from operating activities 4 452 -10 130 -3 922 -20 745 Total Cash flow 1 988 5 161 988 -9 633 * Rounding may occur so that in some cases the amounts do not add up ** For information regarding net sales, please refer to Note 2. *** Open orders includes agreed royalty revenues from FPS
Page 3
2 OPTICEPT TECHNOLOGIES COMMENTS FROM THE CEO Henrik Nettersand, Acting CEO OptiCept Technologies The second quarter of 2026 was a period of significant transformation for OptiCept. We implemented the cost-reduction program, adapted our organization and completed important steps in the transition of our PEF business to FPS. In the period OptiCept delivers a positive operational cash flow and improves the EBITDA with 67%. During the period we have also improved our position within the Plant segment through successful tests in Indonesia. Operational cash flow for the quarter was positive at SEK 4.5 million, compared with negative SEK 10.1 million in the corresponding quarter of the previous year. EBITDA improved to negative SEK 5.4 million, compared with negative SEK 16.5 million in the second quarter of 2025. These improvements reflect the commercial effects of the FPS agreement, actions taken to reduce the cost base and continued focus on cash and working capital. The agreement with FPS, signed in the first quarter of 2026, became effective on 1 April 2026. During the quarter, OptiCept sold and delivered PEF inventory to FPS with a value of approximately SEK 14.4 million and received its first license payment of SEK 7.6 million. The transition to the new commercial model is under way. During the quarter, FPS recorded orders for seven power modules. Under the agreement, the fixed fee of EUR 230,000 per month during 2026 is deducted before the profit-sharing mechanism becomes applicable. Accordingly, no revenue from profit sharing has been recognized during the period. The revenue consists of the fixed fee and the inventory sale. Based on current assumptions regarding the timing and profitability of future projects, we estimate that approximately 80 power modules would need to be delivered before profit sharing is expected to generate material additional revenue for OptiCept beyond the fixed fee. Current OptiCept PEF systems typically comprise one to three power modules per unit. This estimate is inherently dependent on commercial progress & timing, project mix, delivery timing and profitability, and should therefore not be regarded as a forecast. The handover to FPS includes the transfer of products and customer relationships, as well as the establishment of sales, installation and support capabilities within FPS. This requires training, technical familiarization and the integration of OptiCept’s solutions into FPS’s internal processes and commercial offering. During this transition period, OptiCept will continue to provide agreed technical expertise and support. While the ramp-up will take time, the purpose is to establish a scalable platform for future commercial development. FPS has recruited five former OptiCept employees in sales and installation roles. This supports continuity of technical competence and customer knowledge while enabling OptiCept to streamline its organization. Following the restructuring, OptiCept has reduced its workforce to 11 employees. The Company has also closed two warehouses, optimized IT agreements and terminated certain agent and consulting agreements. These actions reduce OptiCept’s fixed-cost base and clarify the Company’s focus on technology, product expertise and support for commercial partners. OptiCept is moving from maintaining much of the commercial infrastructure internally to enabling sales through a larger industrial partner. Based on the progress made and current planning assumptions, I maintain the assessment that OptiCept is expected to achieve positive EBITDA no later than the second half of 2026. Within Plant Tech, tests in Indonesia have produced encouraging results. In South America, a production- environment test is under way and is expected to be completed during the third quarter of 2026. I maintain the assessment that the first commercial order of equipment for cuttings is expected before the end of 2026. OptiCept and EQR, a producer of roses in Ecuador, are also conducting a large-scale trial of sea freight transport of roses from Ecuador to Europe combined with OptiCept’s vacuum impregnation technology. Once the roses arrive in the Netherlands, their quality and vase life will be evaluated. If successful, the trial may support the development of lower-emission logistics alternatives for the flower industry. It remains a trial, and no conclusion regarding commercial adoption can yet be drawn. Starting with the interim report for the second quarter the Group changed its accounting framework from IFRS to K3. The change is intended to reduce administrative costs and to provide reporting that management considers better reflects of the Group’s financial achievement arising from the commercialization agreement with FPS. The transition also coincides with the full amortization of Group goodwill as of 30 June 2026. I look forward to the second half of 2026 with confidence. Henrik Nettersand Acting CEO OptiCept Technologies
Page 4
3 OPTICEPT TECHNOLOGIES ABOUT THE BUSINESS Technology that revolutionizes food and the plant industry OptiCept Technologies AB (publ) provides the food and plant industry with technological solutions that contribute to a more sustainable world and enable climate-smart economic growth. OptiCept optimizes biological processes - Increased extraction from raw material, extended shelf life, reduced waste, and improved quality (taste, aroma, color, nutritional content) of the final product. The positive effects of technology increase efficiency for our customers, better products for the consumers, and minimal impact on our environment. Through patented technology in PEF (pulsed electric field) and VI (Vacuum Infusion), the technology opens up new business opportunities for the food and plant industry worldwide. OptiCept’s vision is to contribute to a sustainable world by offering efficient green cutting-edge technology that is easy to use in the areas of FoodTech and PlantTech. The company is located in Lund and the share is traded on the Nasdaq First North Growth Market. Tapper Partners AB is a Certified Adviser and is available at +46 (0)70 440 10 98 or e-mail: ca@tapperpartners.se
Page 5
4 OPTICEPT TECHNOLOGIES PEF technology is a non-thermal food processing method that uses short high voltage pulses of electrical energy to improve various aspects of food extraction, preservation, quality and safety. By applying high-intensity electrical pulses, the cell membrane is perforated or destroyed and more contents can be extracted from each cell and/or results in the inactivation of microorganisms. PEF technology is gentle, enabling the preservation of nutrients, texture and flavor better than traditional heat methods such as pasteurization or sterilization. Because PEF does not require prolonged heat treatment, sensitive nutrients, antioxidants and color are retained in the food. PEF technology often requires less energy than traditional heat processing. Because PEF can reduce the need for preservatives and high temperatures, it can help extend the shelf life of food products while reducing the need for chemicals in preservation. OptiCept has developed a patented PEF technology (CEPT). The CEPT platform is the basis for the various applications developed for specific foods such as olive oil, juice and wine. Today, the company has developed equipment for several capacity needs, the portfolio includes the L7 series for liquid foods. For solid foods, the S7-series has been developed. ABOUT OUR FOODTECH APPLICATIONS FOODTECH APPLICATIONS The OptiCept L series is developed for the treatment of liquid foods. Currently, two applications have been developed on the platform, LO7 for olive oil and LJ7 for juice. The OptiCept S series is developed for the treatment of solid foods. Currently, two applications have been developed on the platform, SP7 for potato processing and SD7 for optimized drying of fruit and vegetables. OPTI CEPT ® OPTI CEPT ® L-SERIES S-SERIES PEF (Pulsed electric field) - technology for a more sustainable food industry FOODTECH APPLICATIONS
Page 6
5 OPTICEPT TECHNOLOGIES The company’s solutions for the plant industry are based on vacuum impregnation/infusion (VI) technique. Using a vacuum nutrients are introduced into plant tissue. The OptiBoost technology platform is designed to improve the quality and longevity of harvested plant material. ”Boost” cut flowers, ornamental plants or forest cuttings with nutrition. The patented technology controls pressure parameters and in collaboration with specially developed nutrient liquids we ensure that optimal amounts of nutrients are supplied to the plant. Today, the company has developed an application for cut flowers (CF1) and one for cuttings from potted plants and forest cuttings (FC1). OptiBoost for cut flowers brings many advantages, including significantly extended lifespan but also quality aspects such as stronger colors, greener leaves and more even opening of the flower. In cuttings, the method has proven particularly effective in Eucalyptus, which is a very common tree species in the southern hemisphere. Here we improve rooting, survival and quality, which means that forest growers become more efficient in their work. PLANTTECH APPLICATIONS Vacuum impregnation (VI) - quality and efficiency technology for the plant industry ABOUT OUR PLANTTECH APPLICATIONS Extends the vase life of cut flowers by an average of 50%. Improves flower color and produces greener leaves. Improves survival and rooting of cuttings. OptiBoost for cuttings adds an important quality assurance by ensuring that all treated cuttings are impregnated with nutrient liquid. PLANTTECH APPLICATIONS OPTI BOOST ® OPTI BOOST ® CF1 FC1
Page 7
6 OPTICEPT TECHNOLOGIES FINANCIAL INFORMATION FINANCIAL OVERVIEW Introduction The company signed a commercialization agreement with FPS on March 8, securing approximately SEK 156 million in revenues over the next five years. Combined with additional potential income through the profitsharing mechanism, the agreement significantly strengthens the company’s financial position compared with the same period last year. Starting with the interim report for Q2 2026, the group transitions from IFRS to K3 accounting standards, motivated by reduced administrative burden and the belief that K3 provides a more accurate representation of the company’s performance under the FPS agreement. Group Performance Total revenue for April–June amounted to SEK 25.9 million (previous year: SEK 3.2 million). Net sales totaled SEK 23.3 million (1.2 million), and other income SEK 2.6 million (0.1 million). The financial net was SEK - 0.8 million (–0.4 million). Profit after financial items was –16.4 million (–32.0 million). Net sales were largely driven by FPS, totaling SEK 21.1 million, including: • Inventory sales: SEK 14.4 million • License income: SEK 7.6 million • Cost reimbursements: SEK 1.2 million Revenue Recognition Revenue is recognized when OptiCept fulfills its obligations under customer agreements. The largest obligation is the FPS commercialization agreement, which generates a fixed monthly license fee. Equipment and service revenue is recognized upon delivery or completion. Order Intake Order intake for Q2 includes the full FPS agreement (approx. SEK 156 million in accumulated license value), the inventory sale of SEK 14.4 million, and an additional equipment order of SEK 0.9 million. Financing During Q1, loans totaling SEK 44.4 million were converted into shares at SEK 2.15 per share, generating issuance costs of SEK 0.5 million. The credit facility established in Q4 2025 was utilized by SEK 5 million in Q1 and an additional SEK 5 million in Q2. Supplier liabilities to FPS were converted into a convertible loan of SEK 11.1 million, maturing on September 30, 2026, with an annual interest rate of 3.5%. Discussions are ongoing with FPS regarding either conversion or extension to 2027. Shares OptiCept Technologies has been listed on Nasdaq First North Growth Market since May 2020. At the end of the reporting period, the company had 86,088,714 shares outstanding. Earnings per share before and after dilution were –0.19 SEK (–0.51 SEK). Cash Flow For the second quarter, cash flow from operating activities in the Group amounted to SEK 4.5 million (SEK -10.1 million). Cash flow from financing activities amounted to SEK -2.4 million (SEK 17.5 million). Total cash flow for the period amounted to SEK 2.0 million (SEK 5.2 million). Investments Investments for April–June amounted to SEK 0.1 million (2.2 million). The decline is due to fewer new machine types delivered in 2026 and a shift from capitalized development costs to engineering time on commercialized products. Engineering costs have also decreased following staff reductions announced in Q4 2025. Going Concern The group’s continued operations depend on liquidity. Q2 ended with SEK 3.6 million in cash. Over the next 12 months, the company is dependent on converting the SEK 11 million FPS loan maturing in September 2026. If not converted, alternative financing will be required. Warrants A total of 8,467,607 warrants were issued in 2025 across several series (TO 2025/2028 and T08), including warrants issued to management, through directed issues, and in connection with the credit facility. Under K3, warrant value is recognized in equity.
Page 8
7 OPTICEPT TECHNOLOGIES OTHER INFORMATION FINANCIAL INFORMATION Audit This report has not been reviewed by the Company’s auditor. Organization and Personnel Operations are primarily conducted in the parent company, OptiCept Technologies AB, with subsidiaries in China and Spain. The number of employees in the Group was 11 (31) at the end of the period. Of the employees, 9 (25) were men and 2 (6) were women. The Board of Directors is not included in the reporting. Upcoming Financial Reports OptiCept intends to publish financial reports as follows: 1. Publication of interim report Q3 2026 – November 28, 2026 2. Publication of year-end report Q4 2026 – March 5, 2027 Cybersecurity Cyberattacks have become an increasing threat in society and also for OptiCept Technologies, which depends on IT support in its daily operations. The company is continuously working to ensure that it is well prepared to counter cyberattacks and other types of intrusions. Forward-Looking Information Although the Board of Directors and management believe that the expectations presented in this report are reasonable, no assurance can be given that these expectations will prove to be correct. Accordingly, actual future outcomes may differ materially from those expressed in the forward-looking information due to, among other things, changes in economic conditions, market developments, legal and regulatory requirements, climate change, war, pandemics, political actions, and currency fluctuations.
Page 9
8 OPTICEPT TECHNOLOGIES Henrik Nettersand, Acting CEO/CFO Phone: +46 (0) 76 050 61 73 E-Mail: henrik.nettersand@opticept.se For further information BOARD AND CEO CERTIFICATION The board and the managing director hereby certify that the interim report provides a fair overview of the company’s operations, position and results. Lund on August 28, 2026 OptiCept Technologies AB (publ) This information is such information that OptiCept Technologies AB (publ) is obliged to publish according to the EU’s market abuse regulation. The information was submitted through the care of the contact persons below, for publication on August 28, 2026 at 08:00. Carlos Fernandez Villena Chairman Mikael Carleson Board Member Henrik Nettersand Acting CEO/CFO Kees Jansen van Rosendaal Board member Eda Demir Westman Board member
Page 10
9 OPTICEPT TECHNOLOGIES FINANCIAL INFORMATION GROUP INCOME STATEMENT Note Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full Year (Jan-Dec) KSEK(unless otherwise stated)* 2026 2025 2026 2025 2025 Net sales 2 23 302 1 192 31 139 6 470 27 236 Activated work for own account 0 1 968 2 4 412 9 428 Other revenue 2 575 85 2 775 562 674 Subtotal 25 877 3 246 33 916 11 444 37 338 Operating expenses Raw materials and supplies -15 080 -2 650 -18 771 -5 878 -24 272 Other external expenses -8 535 -8 024 -16 197 -17 111 -42 852 Personnel costs -6 212 -8 439 -17 592 -16 361 -33 732 Depreciation & amortization intangible and tangible fixed assets -10 299 -15 062 -25 841 -30 130 -62 084 Other operating costs -1 412 -583 -2 090 -1 387 -10 329 Operating income -15 661 -31 514 -46 575 -59 422 -135 931 Financial incomes -809 82 0 82 3 512 Financial costs 44 -528 -5 836 -1 441 -13 344 Financial net -765 -446 -5 836 -1 359 -9 832 Profit/loss after financial items -16 426 -31 959 -52 412 -60 781 -145 762 Current tax 0 0 0 0 221 Net profit -16 426 -31 959 -52 412 -60 781 -145 541 Earnings per share before and after dilution -0.19 -0.51 -0.68 -0.97 -2.31 Average outstanding number of shares before and after dilution 85 895 127 62 823 850 77 216 844 62 823 850 62 929 387 Number of share at the end of the period 86 088 714 64 394 683 86 088 714 64 394 683 65 144 683 * Rounding may occur so that in some cases the amounts do not add up
Page 11
10 OPTICEPT TECHNOLOGIES GROUP BALANCE SHEET Assets FINANCIAL INFORMATION TSEK Note 2026-06-30 2025-06-30 2025-12-31 Non-current assets Intangible assets Capitalized development costs 40 029 44 531 44 796 Goodwill 0 45 358 19 637 Other intangible assets 8 994 10 656 10 033 Sum intangible assets 49 023 100 546 74 466 Tangible assets Equipment, tools and installations 508 932 706 Sum tangible assets 508 932 706 Financial non-current assets Other shares and financial assets 6 6 6 Other long-term receivables 160 160 160 Sum financial non-current assets 166 166 166 Sum non-current assets 49 696 101 644 75 338 Current assets Inventories Raw materials & supplies 1 651 16 238 11 531 Finished goods inventory 7 792 26 397 16 246 Work-in-progress 0 526 0 Sum inventory 9 443 43 161 27 778 Current receivables Accounts receivable 1 18 925 4 768 14 286 Other receivables 216 1 202 5 028 Prepaid expenses and accrued revenue 3 113 3 618 2 200 Sum current receivables 22 254 9 588 21 514 Cash & bank holdings 3 600 12 043 2 612 Sum current assets 35 298 64 793 51 904 TOTAL ASSETS 84 994 166 437 127 241
Page 12
11 OPTICEPT TECHNOLOGIES GROUP BALANCE SHEET Equity and liabilities FINANCIAL INFORMATION Note 2026-06-30 2025-06-30 2025-12-31 Equity Share capital 3 7 748 5 796 5 863 Translation reserves 17 414 11 Other contributed capital 3 746 468 575 500 703 119 Accrued profit/loss including profit/loss of the year -718 502 -457 946 -665 377 Sum equity 35 731 123 763 43 616 Provisions Provision for guarantees 3 048 832 2 662 Deferred tax liability 1 192 1 413 1 191 Sum provisions 4 240 2 245 3 853 Long-term liabilities Other long-term liabilities 0 0 0 Sum long-term liabilities 0 0 0 Current liabilities Interest-bearing liabilities 3 21 477 15 240 42 817 Customer advance payments 0 0 2 957 Accounts payable 1 1 376 3 522 19 510 Tax liabilities 83 434 448 Other current liabilities 8 647 8 371 1 753 Prepaid expenses and accrued revenue 13 439 12 861 12 286 Sum current liabilities 45 022 40 429 79 771 Sum liabilities 45 022 40 429 79 771 SUM EQUITY AND LIABILITIES 84 994 166 437 127 241
Page 13
12 OPTICEPT TECHNOLOGIES GROUP REPORT ON CASH FLOWS FINANCIAL INFORMATION Note Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year (Jan-Dec) KSEK 2026 2025 2026 2025 2025 Operating activities Profit after financial items -16 426 -31 959 -52 412 -60 781 -145 762 Adjustments 6 8 419 15 804 26 563 31 256 85 323 Paid tax 0 0 0 0 0 Cash flow from operating activities before changes in working capital -8 007 -16 156 -25 849 -29 525 -60 440 Change in working capital Increase/decrease of inventories 18 112 -1 365 20 652 -1 006 -1 770 Increase/decrease of current receivables -1 746 -1 032 -740 886 -11 040 Increase/decrease of current liabilities -3 907 8 423 2 016 8 900 27 849 Cashflow from operating activities 4 452 -10 130 -3 922 -20 745 -45 401 Investing activities Acquisition of intangible assets -59 -2 201 -199 -4 933 -10 587 Acquisition of property, plant and equipment 0 0 0 0 0 Sale of property, plant and equipment 0 0 0 0 0 Cashflow from Investing activities -59 -2 201 -199 -4 933 -10 587 Financing activities Utilization of credit line 5 000 19 003 13 000 19 003 35 516 Loan amortisation -7 178 -9 725 -7 178 -11 173 -11 829 Derivative liability 0 3 559 0 3 559 5 945 Directed share issue 0 5 486 0 5 486 8 018 Share issue costs -227 -831 -713 -831 -831 Issued warrants 0 0 0 0 104 Cashflow from financing activities -2 405 17 492 5 109 16 044 36 923 Cashflow of the period 1 988 5 161 988 -9 633 -19 065 Cash & cash equivalents at beginning of period 1 612 6 883 2 612 21 677 21 677 Cash & cash equivalents at end of period 3 600 12 043 3 600 12 043 2 612 Specification cash & cash equivalents Cash & bank holdings 3 600 12 043 3 600 12 043 2 612 Sum 3 600 12 043 3 600 12 043 2 612
Page 14
13 OPTICEPT TECHNOLOGIES GROUP REPORT ON CHANGES IN EQUITY FINANCIAL INFORMATION KSEK Note Share capital Ongoing unregistered new share issue Translation reserve Other contributed capital Accrued profit/loss including profit/loss of the year Total equity Opening equity 2025-01-01 5 649 0 259 690 100 -519 836 176 172 Net profit -248 -3 -145 541 -145 792 Directed share issue 214 7 804 8 018 Issue costs -831 -831 Options issued to convertible loan lenders 5 945 5 945 Options issued to management 104 104 Opening balance equity 2026-01-01 5 863 0 11 703 119 -665 377 43 616 Net profit 6 3 -52 412 -52 403 Rights issue 3 1 859 0 42 572 44 431 Debt-for -equity swap 3 26 774 800 Issue costs -713 -713 Ending balance equity 2026-06-30 7 748 0 17 746 468 -718 502 35 731
Page 15
14 OPTICEPT TECHNOLOGIES FINANCIAL INFORMATION THE PARENT COMPANY’S INCOME STATEMENT Note Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year (jan-dec) KSEK(unless otherwise stated)* 2026 2025 2026 2025 2025 Net sales 2 23 302 972 31 139 6 825 27 594 Activated work for own account 0 1 968 2 4 412 9 428 Other revenue 2 575 85 2 775 562 674 Subtotal 25 877 3 026 33 916 11 799 37 696 Operating expenses Raw materials and supplies -14 747 -2 546 -18 224 -3 912 -24 907 Other external expenses -8 324 -8 037 -15 804 -17 715 -45 055 Personnel costs -5 827 -8 462 -16 906 -15 930 -33 304 Depreciation & amortization intangible and tangible fixed assets -10 297 -15 055 -25 837 -30 111 -62 053 Other operating costs -1 548 -404 -2 204 -1 123 -8 731 Operating income -14 867 -31 478 -45 057 -56 993 -136 354 Financial incomes -809 120 0 120 3 512 Financial costs 44 -568 -5 836 -1 483 -13 348 Result from shares in subsidiaries 0 0 0 0 -6 128 Financial net -765 -447 -5 836 -1 363 -15 964 Profit/loss after financial items -15 632 -31 925 -50 893 -58 356 -152 318 Current tax 0 0 0 0 221 Net profit -15 632 -31 925 -50 893 -58 356 -152 097 * Rounding may occur so that in some cases the amounts do not add up
Page 16
15 OPTICEPT TECHNOLOGIES BALANCE SHEET OF THE PARENT COMPANY FINANCIAL INFORMATION Assets KSEK Note 2026-06-30 2025-06-30 2025-12-31 Non-current assets Intangible assets Capitalized development costs 40 029 44 531 44 796 Goodwill 0 45 358 19 637 Other intangible assets 8 994 10 656 10 033 Sum intangible assets 49 023 100 546 74 466 Tangible assets Equipment, tools and installations 437 840 631 Sum tangible assets 437 840 631 Financial non-current assets Shares in group companies 125 3 115 125 Other shares and financial assets 6 6 6 Other long-term receivables 160 654 0 Long term claim group companies 0 160 160 Sum financial non-current assets 291 3 935 291 Sum non-current assets 49 751 105 321 75 388 Current assets Inventories Raw materials & supplies 1 651 16 765 11 531 Finished goods inventory 7 792 0 0 Work-in-progress 0 27 632 14 886 Sum inventory 9 443 44 397 26 417 Current receivables Accounts receivable 1 18 925 2 928 13 845 Short term claim on group companies 762 7 159 2 Other receivables 57 1 002 4 822 Prepaid expenses and accrued revenue 3 113 2 631 2 200 Sum current receivables 22 857 13 721 20 869 Cash & bank holdings 3 506 11 880 2 460 Sum current assets 35 806 69 998 49 746 TOTAL ASSETS 85 556 175 319 125 134
Page 17
16 OPTICEPT TECHNOLOGIES FINANCIAL INFORMATIONBALANCE SHEET OF THE PARENT COMPANY Equity and liabilities Note 2026-06-30 2025-06-30 2025-12-31 Equity Share capital 3 7 748 5 796 5 863 Fund for development expense 17 829 19 021 21 213 Total restricted equity 25 576 24 817 27 076 Premium fund 187 377 557 485 144 031 Retained profit or loss -124 926 -391 717 24 499 Profit/loss for the period -50 893 -58 356 -152 097 Total non-restricted equity 11 558 107 412 16 434 Sum equity 37 134 132 229 43 510 Provisions Provision for guarantees 3 048 832 2 662 Deferred tax liability 1 192 1 413 1 192 Sum provisions 4 240 2 245 3 854 Long-term liabilities Other long-term liabilities 0 0 0 Sum long-term liabilities 0 0 0 Current liabilities Interest-bearing liabilities 3 21 477 20 014 42 817 Customer advance payments 0 0 2 957 Accounts payable 1 1 188 3 529 18 208 Tax liabilities 83 434 448 Other current liabilities 7 970 3 515 1 030 Short term liability group companies 25 25 25 Prepaid expenses and accrued revenue 13 439 13 327 12 286 Sum current liabilities 44 182 40 844 77 771 Sum liabilities 44 182 40 844 77 771 SUM EQUITY AND LIABILITIES 85 556 175 319 125 134
Page 18
17 OPTICEPT TECHNOLOGIES N0TES
Page 19
18 OPTICEPT TECHNOLOGIES NOTE 1 - IMPORTANT ACCOUNTING PRINCIPLES NOTES General Principles The consolidated financial statements include OptiCept Technologies AB and its wholly owned Swedish subsidiaries, as well as one wholly owned Chinese subsidiary. The interim report is prepared in accordance with the Swedish Annual Accounts Act (ÅRL) and BFNAR 2012:1 (K3). The parent company’s interim report is prepared under Chapter 9 of the Annual Accounts Act. Assets and liabilities are recognised in accordance with Chapter 11, i.e. at the lower of amortised cost and fair value. Change of Accounting Standard from IFRS to K3 Starting with the June 2026 quarterly report, the group applies the Annual Accounts Act and BFNAR 2012:1 (K3) for interim, annual, and consolidated reporting. Previously, the group applied IFRS as adopted by the EU, together with RFR 1 and RFR 2 for the parent company. The decision to adopt K3 is motivated by reduced administrative burden and the belief that K3 provides a more accurate representation of the group’s and parent company’s financial performance. The transition has been carried out in accordance with K3 Chapter 10, meaning comparative figures for 2025 and Q1 2026 have been restated. The effects of the transition are presented in Note 6. After the transition, the parent company applies the same accounting principles as the group, except where specific rules apply (e.g., accounting for shares in subsidiaries). Revenue Recognition Revenue is recognized when significant risks and rewards are transferred to the customer, which for OptiCept typically occurs upon delivery of equipment. Service revenue is recognized as the service is performed. Net sales for Q2 2026 amount to SEK 23.3 million, of which SEK 23.1 million relates to FPS under the commercialization agreement signed in Q1. All deliveries recognized as revenue have been completed and invoiced. Financing in 2026 The company has financed operations through convertible loans and a directed share issue in 2025. During Q1 2026, most of the 2025 convertible loans were converted into shares. New loans have been drawn under a SEK 10 million credit facility established in late 2025: • SEK 5 million utilized in Q1 • SEK 5 million utilized in Q2 A loan from FPS of SEK 7.2 million was fully amortized in Q2. A supplier liability to FPS was converted into a convertible loan of SEK 11.1 million in Q1. Further details on financing and terms are found in Note 3. Accounting Principle for Warrants The value of all warrants is recognized as equity after the transition from IFRS to K3, at the value they had at issuance. See Note 6 for further details. Financial Net The financial net includes interest income and expenses, as well as unrealized foreign exchange effects on financial assets and liabilities. Trade Receivables and Trade Payables Trade receivables as of June 30, 2026 are expected to be collected during 2026–2027. They are recognized at the amount expected to be received. Cost of goods sold is recognized when the related sale is recognized. Supplier invoices are paid according to agreed terms. Warranty Provision The company has assessed each customer agreement individually and reserved amounts deemed reasonable. The increase in the warranty provision compared with June 2025 is mainly due to materially higher sales during the second half of 2025. Inventory Changes and Writedowns Inventory is measured according to FIFO. The portion of inventory related to the food segment has been delivered to FPS under the commercialization agreement, generating SEK 14.4 million in revenue during Q2. In connection with this delivery, the obsolescence reserve was adjusted from SEK 16.1 million to SEK 13.8 million, a reduction of SEK 2.3 million. Impairment of Shares in Subsidiaries (Parent Company) OptiCept’s subsidiaries in Spain, Hong Kong, and China were established as sales offices. Due to the FPS agreement, these entities are no longer needed, and a decision has been made to liquidate or divest them. As a result, the carrying value of shares in these subsidiaries was written down, and a provision for closure costs was recognized in December 2025. No additional impairment or provisions were required during Q1 2026.
Page 20
19 OPTICEPT TECHNOLOGIES NOTES N0TE 2 - INCOME The Group sales by customer segment* Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year (Jan-Dec) KSEK 2026 2025 2026 2025 2025 FPS licence fee 7 551 0 7 551 0 0 Inventory sale to FPS 14 354 0 14 354 0 0 Cost reimbursements from FPS 1 160 0 1 160 0 0 FoodTech sales 118 960 7 695 6 079 26 823 PlantTech sales 119 232 379 391 413 Net sales 23 302 1 192 31 139 6 470 27 236 Other operating income 2 575 85 2 775 562 674 Sum 25 877 1 277 33 914 7 032 27 910 The Group Foodtech and Planttech sales by country* Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year ( Jan-Dec) KSEK 2026 2025 2026 2025 2025 Sweden 118 314 233 401 2 195 Spain 0 293 0 3 353 16 940 Portugal 0 0 0 0 2 956 Philippines 0 0 3 307 402 402 Costa Rica 0 0 1 674 0 0 Uganda 0 0 1 542 0 0 Other Countries 119 585 1 318 2 314 4 743 Net sales 237 1 192 8 074 6 470 27 236 '* Breakdown of sales in the parent company corresponds in all essential aspects with that of the group
Page 21
20 OPTICEPT TECHNOLOGIES N0TE 3 - ACCOUNTING FOR LOANS, SHARE ISSUES AND DERIVATIVES NOTES Commercialization Agreement Through the commercialization agreement with FPS, the company has secured SEK 150 million in financing, ensuring a monthly cash inflow from April 2026 to March 2031. The future revenue stream does not affect the balance sheet as of March 31, 2026. Loans Overview At the beginning of 2026, the company’s loan portfolio consisted of three separate loans with different terms and maturities: • “The First Loan” from FPS • “The Second Loan” from multiple lenders (many of whom are shareholders) • A credit facility established in Q4 2025 (“The Third Loan”) During Q1, a significant portion of “The Second Loan” was converted into shares. A supplier liability to FPS of SEK 11.1 million was converted into a convertible loan, referred to as “The Fourth Loan”. The First Loan (FPS Shareholder Loan) The FPS shareholder loan, including accrued interest, amounted to SEK 7.1 million at the end of the previous quarter. It was fully amortized during Q2. The Second Loan (Convertible Loan) Convertible loans totaled SEK 40.7 million at the start of 2026. • SEK 3.0 million was paid in Q1 2026 • SEK 37.7 million was paid during 2025 Including accrued interest and fees, the liability amounted to SEK 41.3 million as of December 31, 2025. Lenders received 0.15 TO8 warrants per invested SEK 1. In March 2026, most lenders exercised their right to convert loans into shares: • SEK 39.8 million converted (including SEK 2.0 million accrued interest) • SEK 3.2 million remains unconverted The remaining loan balance as of June 30, 2026 is SEK 3.6 million, with interest at 1.5% per commenced month, maturing January 16, 2027. The Third Loan (Credit Facility + Convertible Loan) The SEK 10 million credit facility was utilized as follows: • SEK 5.0 million in Q1 • SEK 5.0 million in Q2 In March 2026, the lender converted SEK 4.6 million into shares (SEK 4.0 million principal + SEK 0.6 million interest). In Q4 2025, 750,000 TO8 warrants were issued in connection with this loan. Total Conversions Convertible loans converted during 2026: • SEK 39.8 million (Second Loan) • SEK 4.6 million (Third Loan) = SEK 44.4 million total These were converted into 20,665,517 shares at SEK 2.15 per share. Transaction costs for conversions in 2026 total SEK 0.6 million. The Fourth Loan (Converted Supplier Liability) Supplier liabilities to FPS of SEK 11.1 million were converted into a convertible loan with 3.5% annual interest, maturing September 30, 2026, with the possibility of conversion into shares. Net financial items As of the second quarter of 2026, unrealised exchange rate gains and losses related to operations are recognised under other operating income and other operating costs for the first half of 2026 (previously recognised in net financial items; the previous year has not been adjusted as the change is not considered material). Unrealised exchange rate gains related to operations in the second quarter of 2026 amounted to SEK 2.4 million, while unrealised exchange rate losses related to operations during the same period amounted to SEK 1.0 million. Debt for equity swap During Q2, a supplier liability was converted into 290,381 shares, valued at SEK 800,000 (SEK 2.76 per share). Transaction costs: SEK 76,000. Warrants – Series TO8 Total TO8 warrants issued: 8,292,607, originating from: • 1,425,000 (directed issue 2025) • 6,117,607 (Second Loan) • 750,000 (Third Loan) Each warrant entitles the holder to subscribe for one share between May 1 and June 5, 2030. Strike price: the lower of SEK 7.5 or the latest subscription price in any new share issue up to June 5, 2030. Warrants include standard recalculation and antidilution protections.
Page 22
21 OPTICEPT TECHNOLOGIES NOTESN 0 T E 3 - ACCOUNTING FOR LOANS, SHARE ISSUES AND DERIVATIVES Warrants to Management In 2025, the former CEO and current CEO (formerly CFO) received: • 100,000 and 75,000 warrants respectively • Series: 2025/2028 • Strike price: SEK 7.86 • Market value: SEK 1.04 per warrant (valued by Optionspartner AB) Accounting Treatment of Warrants Under K3, all warrants are recognized in equity at their issuance value and are not revalued periodically. Loans are split into: • Interest-bearing liability (loan amount adjusted for transaction costs and accrued interest) • Equity component (value of warrants) Total warrant value: SEK 5.9 million. Shares, Share Capital and Dilution Share count changes during 2026: • +20,653,650 shares (loan conversions) • +290,381 shares (offset issue) Shares outstanding: • 65,144,683 at start of year • 86,088,714 as of June 30, 2026 Dilution: • 33.7% vs June 2025 • 32.2% vs December 2025 Share capital increased from SEK 5,863,021 (Dec 2025) to SEK 7,747,974 (June 2026).
Page 23
22 OPTICEPT TECHNOLOGIES NOTE 4 - TRANSACTIONS WITH RELATED PARTIES Purchase and sale transactions with related parties take place on market terms. The following transactions have taken place with related parties: NOTES During the financial year, the company has conducted transactions with related parties. All transactions have been carried out on arm’s-length terms unless otherwise stated. Disclosures are provided below regarding the nature and extent of the transactions as well as outstanding receivables and liabilities at the end of the period. GROUP Sale of goods and services to related parties Purchase of goods and services from related parties Sale of goods and services to related parties Purchase of goods and services from related parties Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year (Jan-Dec) Full year (Jan-Dec) 2026 2025 2026 2025 2026 2025 2026 2025 2025 2025 Related parties Food Process Solutions 23 065 23 065 23 Anders Hättmark / Confidera Syd AB 303 273 560 692 1 841 Jonas Hagberg / Torsion Invest AB 480 480 776 960 1 776 Björn Wetterling Ulf Hagman / Hajelo AB 27 165 27 330 664 Summa 23 065 0 23 065 0 810 918 1 386 1 982 0 4 281 GROUP Receivables from related parties Payables to related parties Receivables from related parties Payables to related parties Q1-Q2 (Jan-Jun) Q1-Q2 (Jan-Jun) Full year (Jan-Dec) Full year (Jan-Dec) 2026 2025 2026 2025 2025 2025 Related parties Food Process Solutions 7 951 11 338 6 033 17 734 Anders Hättmark / Confidera Syd AB Jonas Hagberg / Torsion Invest AB 6 285 7 909 14 982 Björn Wetterling 0 0 1 066 Ulf Hagman / Hajelo AB Summa 7 951 0 17 623 13 942 0 33 782 The following parties are considered related parties to OptiCept Technologies AB in accordance with the K3 framework: Members of the Board of Directors, the Chief Executive Officer, other key management personnel, and shareholders holding more than 10 percent of the company’s total shares. Related parties also include spouses, domestic partners, dependent children, and legal entities controlled by individuals belonging to the categories above. * Transaction with related parties in the parent company corresponds in all essential aspects with that of the group
Page 24
23 OPTICEPT TECHNOLOGIES NOTE 5 - SPECIFICATION OF THE CASH FLOW STATEMENT NOTES Items that do not affect cash flow The Group Q2 (Apr-Jun) Q1-Q2 (Jan-Jun) Full year (Jan-Dec) TSEK 2026 2025 2026 2025 2025 Depreciation and impairment 10 299 15 062 25 841 30 130 62 084 Other provisions 0 225 387 321 2 150 Inventory write-down -2 317 0 -2 317 0 16 147 Translation differences 6 13 9 159 -250 Accrued interest expenses 431 503 2 643 646 5 191 Total 8 419 15 804 26 563 31 256 85 323
Page 25
24 OPTICEPT TECHNOLOGIES NOTE 6 - EFFECTS OF TRANSITION TO K3 NOTES Group Reporting Starting with the June 2026 quarterly closing, the annual and consolidated financial statements are prepared in accordance with the Swedish Annual Accounts Act and BFNAR 2012:1 (K3). As stated in note 1: These principles have been applied to the consolidated financial statements as of June 30, 2026, the comparative figures for June 30, 2025, and the opening balance sheets as of January 1, 2026 and January 1, 2025. The transition is accounted for under K3 Chapter 10, which governs changes in accounting policies, revised estimates, and correction of errors. Because the group previously transitioned to K3 under Chapter 35 — and that chapter may only be applied once — Chapter 10 is used for this transition. Under K3, an opening balance sheet is prepared in which K3’s recognition and measurement principles are applied retroactively. Amounts previously reported under IFRS have been adjusted accordingly. The effects are shown in accompanying tables and notes. Key Accounting Changes Affecting the Group Leases Under IFRS 16, all leases were recognized as right-of-use assets and lease liabilities. Under K3, all leases are expensed linearly, and this change is applied retroactively. Goodwill Goodwill was previously not amortised, in accordance with IFRS 3. Under K3, an amortisation period of five years is applied. An adjustment is made so that the carrying amount of goodwill corresponds to the amount it would have had if an amortisation period of five years had been applied from the outset. Financial Statements Format The consolidated financial statements no longer include a statement of comprehensive income, as this is not required under K3. Provisions Provisions have been reclassified from longterm liabilities to a separate section in the balance sheet. Warrants The value of all warrants is now recognized in equity at their original issuance value, and is not remeasured after the transition from IFRS to K3.
Page 26
25 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s opening balance sheet as at 2025-01-01 has been prepared as follows: Assets 2024-12-31 2024-12-31 KSEK Com- ment OB 2024-12-31 in IFRS Adjust- ments OB in K3 2025-01-01 Non-current assets Intangible assets Capitalized development costs 42 999 0 42 999 Goodwill a) 257 216 -186 136 71 080 Other intangible assets 11 423 0 11 423 Sum intangible assets 311 637 -186 136 125 502 Tangible assets Equipment, tools and installations 1 176 0 1 176 Right-of-use assets b) 5 347 -5 347 0 Sum tangible assets 6 524 -5 347 1 176 Financial non-current assets Other shares and financial assets 0 0 0 Other long-term receivables 160 0 160 Sum financial non-current assets 160 0 160 Sum non-current assets 318 321 -191 483 126 838 Current assets Inventories Raw materials & supplies 12 137 0 12 137 Finished goods inventory 30 018 0 30 018 Work-in-progress 0 0 0 Sum inventory 42 155 0 42 155 Current receivables Accounts receivable 6 294 0 6 294 Other receivables 1 678 0 1 678 Prepaid expenses and accrued revenue b) 2 201 302 2 502 Sum current receivables 10 173 302 10 474 Cash & bank holdings 21 677 0 21 677 Sum current assets 74 005 302 74 307 TOTAL ASSETS 392 326 -191 181 201 145 Equity and liabilities Com- ment OB 2024-12-31 in IFRS Adjust- ments OB in K3 2025-01-01 Equity Share capital 5 649 0 5 649 Ongoing but not yet registered share issue 0 0 0 Translation reserves 259 0 259 Other contributed capital 690 100 0 690 100 Accrued profit/loss including profit/loss of the year -333 767 -186 069 -519 836 Sum equity 362 241 -186 069 176 172 Long-term liabilities Provision for guarantees d) 0 511 511 Deferred tax liability 0 511 511 Sum long-term liabilities Long-term liabilities b) 3 680 -3 680 0 Lease liabilities, non-current 0 0 0 Other long-term liabilities d) 511 -511 0 Provision for guarantees b) 1 396 17 1 413 Deferred tax liability 5 588 -4 175 1 413 Current liabilities Interest-bearing liabilities 10 973 0 10 973 Derivative c) 0 0 0 Lease liabilities, current 1 448 -1 448 0 Customer advance payments 0 0 0 Accounts payable 1 564 0 1 564 Tax liabilities 519 0 519 Other current liabilities 1 564 0 1 564 Prepaid expenses and accrued revenue 8 428 0 8 428 Sum current liabilities 24 497 -1 448 23 048 Sum liabilities 30 085 -5 624 24 461 SUM EQUITY AND LIABILITIES 392 326 -191 181 201 145
Page 27
26 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s consolidated balance sheet in accordance with K3 as at 2025-06-30 has been prepared as follows: Assets 2025-06- 30 2025-06- 30 KSEK Com- ment OB 2025-06 in IFRS Adjust- ments made in OB 2025 Adjust- ments in 2025 OB in K3 2026-01-01 Non-current assets Intangible assets Capitalized development costs 44 531 0 0 44 531 Goodwill a) 257 216 -186 136 -25 722 45 358 Other intangible assets 10 656 0 0 10 656 Sum intangible assets 312 403 -186 136 -25 722 100 546 Tangible assets Equipment, tools and installations 932 0 0 932 Right-of-use assets b) 4 576 -5 347 772 0 Sum tangible assets 5 508 -5 347 772 932 Financial non-current assets Other shares and financial assets 6 0 0 6 Other long-term receivables 160 0 0 160 Sum financial non-current assets 166 0 0 166 Sum non-current assets 318 077 -191 483 -24 950 101 644 Current assets Inventories Raw materials & supplies 16 238 0 0 16 238 Finished goods inventory 26 397 0 0 26 397 Work-in-progress 526 0 0 526 Sum inventory 43 161 0 0 43 161 Current receivables Accounts receivable 4 768 0 0 4 768 Other receivables 1 202 0 0 1 202 Prepaid expenses and accrued revenue b) 3 320 302 -4 3 618 Sum current receivables 9 290 302 -4 9 588 Cash & bank holdings 12 043 0 0 12 043 Sum current assets 64 495 302 -4 64 793 TOTAL ASSETS 382 572 -191 181 -24 953 166 437 Equity and liabilities Com- ment OB 2025-06 in IFRS Adjust- ments made in OB 2025 Adjust- ments in 2025 OB in K3 2026-01-01 Equity Share capital 5 796 0 0 5 796 Ongoing but not yet registered share issue 0 0 0 0 Translation reserves 0 0 0 0 Other contributed capital 572 354 0 3 559 575 914 Accrued profit/loss including profit/loss of the year -246 155 -186 069 -25 723 -457 946 Sum equity 331 995 -186 069 -22 163 123 763 Long-term liabilities Provision for guarantees d) 0 511 321 832 Deferred tax liability d) 0 1 413 0 1 413 Sum long-term liabilities 0 1 925 321 2 245 Long-term liabilities Lease liabilities, non-current b) 3 197 -3 680 483 0 Other long-term liabilities 0 0 0 0 Provision for guarantees d) 832 -511 -321 0 Deferred tax liability b), d) 1 396 -1 396 0 0 Sum long-term liabilities 5 426 -5 588 162 0 Current liabilities Interest-bearing liabilities 15 240 0 0 15 240 Derivative c) 3 559 0 -3 559 0 Lease liabilities, current b), d) 1 163 -1 448 285 0 Customer advance payments 0 0 0 0 Accounts payable 3 522 0 0 3 522 Tax liabilities 434 0 0 434 Other current liabilities 8 371 0 0 8 371 Prepaid expenses and accrued revenue 12 861 0 0 12 861 Sum current liabilities 45 151 -1 448 -3 273 40 429 Sum liabilities 50 577 -7 037 -3 111 40 429 SUM EQUITY AND LIABILITIES 382 572 -191 181 -24 953 166 437
Page 28
27 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s balance sheet in accordance with K3 as at 2025-12-31 has been prepared as follows: Assets 2025-12-31 2025-12-31 KSEK Com- ment OB 2025-06 in IFRS Adjustments made in OB 2025 Adjust- ments in 2025 OB in K3 2026-01-01 Non-current assets Intangible assets Capitalized development costs 44 796 0 0 44 796 Goodwill a) 257 216 -186 136 -51 443 19 637 Other intangible assets 10 033 0 0 10 033 Sum intangible assets 312 045 -186 136 -51 443 74 466 Tangible assets Equipment, tools and installations 706 0 0 706 Right-of-use assets b) 4 138 -5 347 1 209 -0 Sum tangible assets 4 844 -5 347 1 209 706 Financial non-current assets Other shares and financial assets 6 0 0 6 Other long-term receivables 160 0 0 160 Sum financial non-current assets 166 0 0 166 Sum non-current assets 317 055 -191 483 -50 234 75 338 Current assets Inventories Raw materials & supplies 11 531 0 0 11 531 Finished goods inventory 16 246 0 0 16 246 Work-in-progress 0 0 0 0 Sum inventory 27 778 0 0 27 778 Current receivables Accounts receivable 14 286 0 0 14 286 Other receivables 5 028 0 0 5 028 Prepaid expenses and accrued revenue b) 1 942 302 -43 2 200 Sum current receivables 21 256 302 -43 21 514 Cash & bank holdings 2 612 0 0 2 612 Sum current assets 51 646 302 -43 51 904 TOTAL ASSETS 368 700 -191 181 -50 277 127 241 Equity and liabilities Com- ment OB 2025-06 in IFRS Adjustments made in OB 2025 Adjust- ments in 2025 OB in K3 2026-01-01 Equity Share capital 5 863 0 0 5 863 Ongoing but not yet registered share issue 0 0 0 0 Translation reserves 11 0 0 11 Other contributed capital 697 174 0 5 945 703 119 Accrued profit/loss including profit/ loss of the year -424 255 -186 069 -55 053 -665 377 Sum equity 278 793 -186 069 -49 108 43 616 Long-term liabilities Provision for guarantees d) 0 511 2 151 2 662 Deferred tax liability b), d) 0 1 413 -222 1 191 Sum long-term liabilities 0 1 925 1 929 3 853 Long-term liabilities Lease liabilities, non-current b) 2 877 -3 680 803 -0 Other long-term liabilities 0 0 0 0 Provision for guarantees d) 2 662 -511 -2 151 0 Deferred tax liability b), d) 1 175 -1 396 221 0 Sum long-term liabilities 6 714 -5 588 -1 126 -0 Current liabilities Interest-bearing liabilities 42 817 0 0 42 817 Derivative c) 2 338 0 -2 338 0 Lease liabilities, current b) 1 083 -1 448 366 0 Customer advance payments 2 957 0 0 2 957 Accounts payable 19 510 0 0 19 510 Tax liabilities 448 0 0 448 Other current liabilities 1 753 0 0 1 753 Prepaid expenses and accrued revenue 12 286 0 0 12 286 Sum current liabilities 83 192 -1 448 -1 972 79 771 Sum liabilities 89 906 -7 037 -3 098 79 771 SUM EQUITY AND LIABILITIES 368 700 -191 181 -50 277 127 241
Page 29
28 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s equity has been affected by the transition to K3 as follows: KSEK Comment Share capital Ongoing unregistered new share issue Translation reserve Other contributed capital Accrued profit/loss including profit/loss of the year Total parent company shareholders Holdings non- controlling interests Total equity Opening balance equity 2025-01-01 in IFRS 5 649 0 259 690 100 -333 767 362 241 0 362 241 Effect on Opening balance of transition to K3 of: - Goodwill a) -186 136 -186 136 -186 136 - IFRS 16 b) 66 66 66 - Revaluation of stock options 0 0 0 Opening balance equity 2025-01-01 in K3 5 649 0 259 690 100 -519 836 176 172 0 176 172 Net profit jan-dec 2025 in IFRS 155 1 -35 060 -34 904 -34 904 Rights issue 146 5 342 5 488 5 488 Issue costs -831 -831 -831 Effect on annual net profit by transition to K3 a) -25 722 -25 722 -25 722 Effect on other contributed capital by transition to K3 c) 3 559 3 559 3 559 Closing balance equity 2025-06-30 in IFRS 5 795 0 414 698 171 -580 618 123 763 0 123 763 Net profit jun-dec 2025 in IFRS -403 -3 -55 428 -55 834 -55 834 Rights issue 68 2 462 2 530 2 530 Stock options issued to management 104 104 104 Effect on annual net profit by transition to K3 a), b), c) -29 332 -29 332 -29 332 Effect on other contributed capital by transition to K3 c) 2 386 2 386 2 386 Closing balance equity 2025-12-31 in K3 5 863 0 11 703 120 -665 378 43 616 0 43 616 Net profit jan-mar 2026 in IFRS 6 3 -43 993 -43 984 -43 984 Rights issue 1 859 0 42 572 44 431 44 431 Debt for equity swap 26 774 800 800 Issue costs -713 -713 -713 Effect on annual net profit by transition to K3 a), b), c) -8 420 -8 420 -8 420 Closing balance equity 2025-06-30 in K3 7 748 0 17 746 469 -718 504 35 731 0 35 731
Page 30
29 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s income statement in accordance with K3 as at 2025-06-30 has been prepared as follows: Comment 2025-06 in IFRS Adjustments 2025-06 in K3 KSEK(unless otherwise stated)* Net sales 6 470 0 6 470 Activated work for own account 4 412 0 4 412 Other revenue 562 0 562 Total revenues 11 444 0 11 444 Operating expenses Raw materials and supplies -5 878 0 -5 878 Other external expenses b) -16 260 -851 -17 111 Personnel costs -16 361 0 -16 361 Depreciation & amortization intangible and tangible fixed assets a), b) -5 180 -24 950 -30 130 Other operating costs -1 387 0 -1 387 Operating income -33 621 -25 801 -59 422 Financial incomes 82 0 82 Financial costs b) -1 521 80 -1 441 Financial net -1 439 80 -1 359 Profit/loss after financial items -35 060 -25 721 -60 781 Current tax 0 -0 0 Net profit -35 060 -25 721 -60 781
Page 31
30 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s income statement for the second quarter of 2025 in accordance with K3 has been prepared as follows: Comment 2025-06 in IFRS Adjustments 2025-06 in K3 KSEK(unless otherwise stated)* Net sales 1 192 0 1 192 Activated work for own account 1 968 0 1 968 Other revenue 85 0 85 Total revenues 3 246 0 3 246 Operating expenses Raw materials and supplies -2 650 0 -2 650 Other external expenses b) -7 598 -426 -8 024 Personnel costs -8 439 0 -8 439 Depreciation & amortization intangible and tangible fixed assets a), b) -2 587 -12 475 -15 062 Other operating costs -583 0 -583 Operating income -18 613 -12 900 -31 514 Financial incomes 82 0 82 Financial costs b) -567 39 -528 Financial net -485 39 -446 Profit/loss after financial items -19 098 -12 862 -31 959 Current tax 0 0 0 Net profit -19 098 -12 861 -31 959
Page 32
31 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 The Group’s income statement in accordance with K3 as at 2025-12-31 has been prepared as follows: Comment 2025 in IFRS Adjustments 2025 in K3 KSEK(unless otherwise stated)* Net sales 27 236 0 27 236 Activated work for own account 9 428 0 9 428 Other revenue 674 0 674 Total revenues 37 338 0 37 338 Operating expenses Raw materials and supplies -24 272 0 -24 272 Other external expenses b) -41 110 -1 742 -42 852 Personnel costs -33 732 0 -33 732 Depreciation & amortization intangible and tangible fixed assets a), b) -12 226 -49 858 -62 084 Other operating costs -10 329 0 -10 329 Operating income -84 331 -51 600 -135 931 Financial incomes 3 512 0 3 512 Financial costs b), c) -9 890 -3 454 -13 344 Financial net -6 378 -3 454 -9 832 Profit/loss after financial items -90 709 -55 053 -145 762 Current tax 221 0 221 Net profit -90 488 -55 053 -145 541
Page 33
32 OPTICEPT TECHNOLOGIES NOTES NOTE 6- EFFECTS OF TRANSITION TO K3 Commentary on Effects of Transition to K3 a. Goodwill Under IFRS, goodwill was treated as an asset with an indefinite useful life and therefore, not depreciated, but instead tested annually for impairment. Under K3, goodwill must be depreciated over five years unless another period can be reliably determined. This change results in significant amortization effects: • SEK 186,136 thousand in accumulated amortization recognized in the opening balance as of 2025 01 01 • SEK 51,443 thousand charged to depreciation/amortization for the 2025 financial year • SEK 12,860 thousand charged for Q1 2026 • SEK 6,776 thousand charged for Q2 2026 Goodwill is fully amortized as of June 30, 2026. b. Leases Under IFRS 16, all leases were recognized on the balance sheet as right of use assets and lease liabilities. Under K3, leases must be classified as operating or finance leases, and most leases are expensed linearly over the contract term. Effects on the opening balance sheet (2025 01 01): • Right of use assets removed: SEK 5,347 thousand • Lease liabilities removed: SEK 3,680 thousand Further effects due to terminated lease contracts: • For FY 2025: o Reduction in right of use assets: SEK 1,209 thousand o Reduction in lease liabilities: SEK 803 thousand • For Q1 2026: o Reduction in right of use assets: SEK 286 thousand o Reduction in lease liabilities: SEK 305 thousand The reversal of IFRS 16 affects several income statement items: • Other external expenses • Depreciation/amortization • Financial expenses • Income tax Lease expense effects under K3: • SEK 3 thousand expense recognized for FY 2025 • SEK –8 thousand (cost reduction) recognized for H1 2026 c. Revaluation of Warrants Under IFRS, warrants issued to lenders were recognized as derivative liabilities and measured at fair value each period. Under K3, warrants are recognized in equity at their issuance value, with no periodic remeasurement. Key effects: • No opening derivative liability existed as of 2025 01 01 • Under IFRS, a derivative liability of SEK 2,338 thousand was recognized for FY 2025 • Under K3, warrants are recognized in equity at SEK 5,945 thousand This results in a negative earnings impact of SEK 3,608 thousand in 2025 (lower profit under K3). For Jan–Jun 2026: • IFRS recognized a revaluation expense of SEK 4,433 thousand • Under K3, this expense does not exist → Result impact is positive SEK 4,433 thousand in 2026. d. Provisions Provisions of SEK 1,925 thousand were reclassified in the opening balance sheet (2025 01 01) from long term liabilities (IFRS) to a separate “Provisions” section under K3. The corresponding amounts were: • SEK 2,662 thousand in the closing balance for 2025 • SEK 4,240 thousand in the closing balance as of June 30, 2026 Parent Company The parent company is affected by the transition to K3 in two areas: • Reclassification of provisions from long term liabilities to a separate section • Valuation of warrants
Page 34
33 OPTICEPT TECHNOLOGIES Unleashing the full potential of organic material Skiffervägen 12 224 78 Lund Sweden +46 (0)46 152 300 info@opticept.se opticept.se OptiCept Technologies AB (publ) FINANCIAL CALENDAR Henrik Nettersand, Acting CEO Phone: +46 (0) 76 050 61 73 E-mail: henrik.nettersand@opticept.se 2026-11-28 2027-03-05 Interim Report Q3 2026 Year-end Report 2026